What is the treatment for acute urticaria (hives) with sudden onset?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Acute Urticaria (Hives) with Sudden Onset

Second-generation non-sedating H1 antihistamines are the first-line treatment for acute urticaria, with doses that can be increased up to four times the standard dose for inadequate symptom control. 1, 2

First-Line Treatment: Antihistamines

  • Second-generation non-sedating H1 antihistamines (cetirizine, desloratadine, fexofenadine, levocetirizine, loratadine, mizolastine) should be used as initial therapy due to their favorable efficacy and safety profile 1, 2
  • For rapid relief, cetirizine may be advantageous as it has the shortest time to attain maximum concentration 3
  • If symptom control is inadequate with standard dosing, increase the dose up to 4 times the standard dose when benefits outweigh risks 1, 2, 4
  • Try at least two different non-sedating antihistamines as individual responses and tolerance vary between patients 1, 2
  • First-generation antihistamines should generally be avoided due to sedation and potential to worsen reactions 1, 5

Adjunctive Treatments for Acute Urticaria

  • Cooling antipruritic lotions (calamine or 1% menthol in aqueous cream) can provide symptomatic relief of itching 2, 3
  • Short courses of systemic corticosteroids may be considered for severe acute urticaria until symptoms resolve to grade 1, though evidence is mixed 1, 6
  • The addition of corticosteroids to antihistamines did not improve symptoms compared to antihistamine alone in two out of three randomized controlled trials 6
  • For severe cases with angioedema or signs of anaphylaxis, epinephrine is the first-line treatment 1

Treatment Algorithm for Persistent or Severe Cases

If acute urticaria persists beyond 6 weeks, it becomes classified as chronic urticaria, requiring a stepped approach:

  1. Step 1: Standard dose second-generation H1 antihistamine 7
  2. Step 2: Increase antihistamine dose up to 4x standard dose if inadequate control 7
  3. Step 3: Add omalizumab 300 mg every 4 weeks (can be increased up to 600 mg every 14 days in patients with insufficient response) 7
  4. Step 4: Consider cyclosporine for patients who don't respond to high-dose antihistamines and omalizumab 7

Important Considerations and Precautions

  • Identify and minimize aggravating factors such as overheating, stress, alcohol, and certain medications (aspirin, NSAIDs, codeine) 2, 3
  • NSAIDs should be avoided in aspirin-sensitive patients with urticaria 2, 3
  • ACE inhibitors should be avoided in patients with angioedema without wheals 2, 3
  • For patients with renal impairment, avoid acrivastine in moderate renal impairment, and halve the dose of cetirizine, levocetirizine, and hydroxyzine 2
  • For patients with hepatic impairment, avoid mizolastine in significant hepatic impairment 2

Monitoring and Follow-up

  • Most cases of acute urticaria are self-limited and resolve within days to weeks 8
  • If symptoms persist beyond 6 weeks, reclassify as chronic urticaria and consider further diagnostic workup 8
  • More than half of patients with chronic urticaria will have resolution or improvement of symptoms within a year 8

References

Guideline

Treatment of Severe Hives (Urticaria)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Urticaria Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Urticaria Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pharmacotherapy of chronic spontaneous urticaria.

Expert opinion on pharmacotherapy, 2013

Research

Treatment of acute urticaria: A systematic review.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Acute and Chronic Urticaria: Evaluation and Treatment.

American family physician, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.